<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03746210</url>
  </required_header>
  <id_info>
    <org_study_id>NICETIES</org_study_id>
    <nct_id>NCT03746210</nct_id>
  </id_info>
  <brief_title>Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis</brief_title>
  <acronym>NICETIES</acronym>
  <official_title>Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bonn</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to analyze non-invasive characterization focal liver lesions in patients with
      liver cirrhosis. The diagnostic accuracy and predictive value of non-invasive methods is
      studied.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to analyze non-invasive characterization focal liver lesions in patients with
      liver cirrhosis. The diagnostic accuracy and predictive value of non-invasive methods is
      studied.

      Upon diagnosis multiparametric ultrasound imaging of the lesions as well as sarcopenia
      parameters are performed for characterization of the lesions. For primary endpoint the
      results are then analyzed with regard to diagnostic accuracy compared to gold standard (CT,
      MRI or histology). For secondary endpoint, predictive value of the non-invasive diagnostics
      are analyzed with regards to mortality and response to treatment.

      All work up, treatment and follow up are applied in standard of care fashion.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2027</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy</measure>
    <time_frame>1 year</time_frame>
    <description>The diagnostic accuracy of non-invasive imaging of focal liver lesions in liver cirrhosis compared to gold standard (histology, CT and/or MRI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predictive Value</measure>
    <time_frame>up to 5 years</time_frame>
    <description>The predictive value on mortality and treatment response of non-invasive imaging of focal liver lesions in liver cirrhosis</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Liver Cirrhoses</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Standard diagnostic procedures</intervention_name>
    <description>B-Mode ultrasound, Duplex sonography, contrast-enhanced ultrasound, elastography, CT, MRI, anthropometrics</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study includes all adult patients in our institution with liver cirrhosis and
        diagnosis of focal liver lesions. Non-invasive charaterization (multiparametric ultrasound,
        sarcopenia assessment) and standard of care work up, treatment and follow up is applied to
        all patients.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients with focal liver lesions and liver cirrhosis

        Exclusion Criteria:

          -  no consent

          -  under 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Praktiknjo, MD</last_name>
    <phone>+4922828715770</phone>
    <email>michael.praktiknjo@ukbonn.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Johannes Chang, MD</last_name>
    <phone>+4922828715770</phone>
    <email>johannes.chang@ukbonn.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Praktiknjo, MD</last_name>
      <phone>+49228 28715770</phone>
      <email>michael.praktiknjo@ukbonn.de</email>
    </contact>
    <contact_backup>
      <last_name>Johannes Chang, MD</last_name>
      <phone>+49228 28715770</phone>
      <email>johannes.chang@ukbonn.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>November 14, 2018</study_first_submitted>
  <study_first_submitted_qc>November 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2018</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Bonn</investigator_affiliation>
    <investigator_full_name>Michael Praktiknjo</investigator_full_name>
    <investigator_title>Principal Investigator / Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

